These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22374524)
21. [Complications associated with short-term intensive consolidation chemotherapy for adults with acute myelogenous leukemia]. Nagata K; Abe Y; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K Gan To Kagaku Ryoho; 1993 Sep; 20(12):1869-72. PubMed ID: 8379681 [No Abstract] [Full Text] [Related]
22. [Recent advance on chemotherapy of leukemia]. Nakamura T; Ueda T Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1531-7. PubMed ID: 7798745 [No Abstract] [Full Text] [Related]
23. More on the treatment of relapsed acute myeloid leukemia. Capizzi RL Oncology (Williston Park); 1989 Oct; 3(10):72-4. PubMed ID: 2701211 [No Abstract] [Full Text] [Related]
24. [Survival in adults with acute myelogenous leukemia]. Tangen JM; Fløisand Y; Foss-Abrahamsen J; Haukås E; Naess IA; Skjelbakken T Tidsskr Nor Laegeforen; 2008 May; 128(10):1164-7. PubMed ID: 18480864 [TBL] [Abstract][Full Text] [Related]
25. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission. Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211 [No Abstract] [Full Text] [Related]
26. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible? Park JH; Tallman MS Expert Rev Hematol; 2011 Aug; 4(4):427-36. PubMed ID: 21801134 [TBL] [Abstract][Full Text] [Related]
27. [Preliminary study on postremission therapy courses in acute myeloid leukemia]. Mi Y; Bian S; Xue Y Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):520-3. PubMed ID: 11769676 [TBL] [Abstract][Full Text] [Related]
28. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393 [TBL] [Abstract][Full Text] [Related]
29. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia. Vogler WR; Velez-Garcia E; Omura G; Raney M Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581 [No Abstract] [Full Text] [Related]
30. Acute promyelocytic leukemia: clinical aspects and results of treatment in 62 patients. Petti MC; Avvisati G; Amadori S; Baccarani M; Guarini AR; Papa G; Rosti GA; Tura S; Mandelli F Haematologica; 1987; 72(2):151-5. PubMed ID: 3114070 [No Abstract] [Full Text] [Related]
31. Acute myeloid leukemia. Rubnitz JE; Gibson B; Smith FO Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314 [TBL] [Abstract][Full Text] [Related]
35. Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Bassan R; Barbui T Haematologica; 1995; 80(1):82-90. PubMed ID: 7758997 [TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia. Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661 [TBL] [Abstract][Full Text] [Related]
37. Relapse and death during first remission in acute myeloid leukemia. Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012 [No Abstract] [Full Text] [Related]